ARCHIVES

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

NCI Launches ALCHEMIST

September 5, 2014

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003